Home
Conditions
Melanoma (Skin)

Clinical trial condition

Melanoma (Skin)

Explore clinical trials studying Melanoma (Skin). Study availability and eligibility vary by location and protocol.

255 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Melanoma (Skin) trial results

Completed

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

NCT00004022

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

NCT00091143

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery

NCT00014092

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Saint Francis Memorial Hospital San Francisco, California, United States

John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

NCT00003229

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

Cancer Center, University of Virginia HSC Charlottesville, Virginia, United States

View Trial Details

Completed

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma

NCT00004244

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

NCT00104845

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

NCT00512889

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

NCT00003665

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

NCT00002754

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

NCT00004148

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States

View Trial Details

Melanoma (Skin)

Melanoma (Skin) trial results

Related conditions